BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1146463)

  • 1. [Preliminary results of immuno-surgical treatment of primary melanoma (author's transl)].
    Vanwicjk R; Rustin P; Malek-Mansour S; Castermans-Elias S; Castermans A
    Acta Chir Belg; 1975 Jul; 74(4):430-40. PubMed ID: 1146463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
    Illig L; Paul E
    Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosurgical approach to the treatment of malignant melanoma using 2,4-dinitrochlorobenzene (DNCB).
    Lukács L; István M
    Neoplasma; 1984; 31(4):437-45. PubMed ID: 6472514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
    Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
    Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
    Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution to treatment of malignant melanoblastoma by the local application of DNCB (author's transl)].
    Duchková H; Richter J; Kubíková M
    Cesk Dermatol; 1978 Jun; 53(3):169-72. PubMed ID: 679282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific immune reactivity in patients with malignant melanoma (author's transl)].
    Poljak-Blazi M; Montani D; Ferle-Vidović A; Boranić M
    Lijec Vjesn; 1977 Dec; 99(12):735-8. PubMed ID: 607047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
    Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant DNCB immunotherapy in malignant melanoma].
    Weidner F; Djawari D
    Z Hautkr; 1979 May; 54(10):436-43. PubMed ID: 473840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
    Vanwijck R; Bouillenne C; Malek-Mansour S
    Eur J Cancer (1965); 1975 Apr; 11(4):267-76. PubMed ID: 1079770
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of local immunomodulation with DNCB in cases of advanced melanoma of the skin].
    Budzanowska E; Pawlicki M
    Przegl Dermatol; 1988; 75(1):29-34. PubMed ID: 3290999
    [No Abstract]   [Full Text] [Related]  

  • 13. Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years).
    Illig L; Paul E; Bödeker RH
    Anticancer Res; 1984; 4(4-5):293-8. PubMed ID: 6486734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
    McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma.
    Hsueh EC; Famatiga E; Shu S; Ye X; Morton DL
    Ann Surg Oncol; 2004 Oct; 11(10):892-9. PubMed ID: 15383418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decrease in immunoreactivity in melanoma. Analysis of DNCB tests in the literature].
    Remy W; Dorn R; Ulm K; Mayerhausen W
    Z Hautkr; 1986 Dec; 61(24):1767-77. PubMed ID: 3825218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary free dermatoplasty in surgical treatment of skin melanoma].
    Zhukov VM
    Vopr Onkol; 1977; 23(4):3-9. PubMed ID: 329578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secretion of immunoglobulins in malignant melanoma of the skin].
    Babakova SV; Kuznetsov VA; Gorodilova VV; Konradov AA; Chervonnaia LV
    Vopr Onkol; 1988; 34(3):314-8. PubMed ID: 3358294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous malignant melanomas. A study of 13 cases observed in a general surgery department (author's transl)].
    Yangni-Angate A; Khoury J; Kanga M; Zeze B; Turquin H; Guhl G; Echimane A; Merrien Y
    Med Trop (Mars); 1982; 42(1):83-7. PubMed ID: 7078382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.